Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 3, 2007

Phyton Acquires Glyco-Engineering Technique

  • Phyton Biotech acquired Dow Chemical’s technology and intellectual property platform for the engineering of glycosylation in pharmaceutical protein products.

    This transaction will be enhanced through a research collaboration with the Dutch research institute Plant Research International, part of Wageningen University & Research Centre and one of the innovators of the technology platform, according to Phyton.

    The Dow agreement coincides with the installation of a second 75,000-liter bioreactor at Phyton’s German cell fermentation facility.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »